Präsentations-Hub

Präsentations-Hub

Willkommen im Präsentations-Hub, wo Sie individuelle Präsentationen erstellen, bearbeiten, speichern und exportieren können, indem Sie aus unserem Angebot an bildenden Foliensätzen auswählen.

Bitte geben Sie mindestens 3 Zeichen ein
Featured
NEUIGKEITEN

Empfohlener Inhalt

COVID-19 and its implications in heart failure
PRÄSENTATION
COVID-19 and its implications in heart failure
Inhalt anzeigen
Can new-onset diabetes be prevented
PRÄSENTATION
Can new-onset diabetes be prevented
Inhalt anzeigen
Practicalities of SGLT2 inhibition – pros vs cons
Infografik
Practicalities of SGLT2 inhibition – pros vs cons
Inhalt anzeigen
Updates on ESC heart failure guidelines
VIDEO
Updates on ESC heart failure guidelines
Inhalt anzeigen
Cardiologist Practical Guide to Prescribing
Infografik
Cardiologist Practical Guide to Prescribing
Inhalt anzeigen
Cardiovascular
NEUIGKEITEN

Herz-Kreislauf

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
PRÄSENTATION
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Inhalt anzeigen
What did the study tell us about the safety of medicines in heart failure?
PRÄSENTATION
What did the study tell us about the safety of medicines in heart failure?
Inhalt anzeigen
Hiding in plain sight – how to detect heart failure in primary care
PRÄSENTATION
Hiding in plain sight – how to detect heart failure in primary care
Inhalt anzeigen
Optimizing HF discharge care and follow-up
PRÄSENTATION
Optimizing HF discharge care and follow-up
Inhalt anzeigen
Alle Herz-Kreislauf-Präsentationen anzeigen
Infection and Vaccines
NEUIGKEITEN

Infektionen und Impfstoffe

Hiding in plain sight – how to detect heart failure in primary care
PRÄSENTATION
Hiding in plain sight – how to detect heart failure in primary care
Inhalt anzeigen
Optimizing HF discharge care and follow-up
PRÄSENTATION
Optimizing HF discharge care and follow-up
Inhalt anzeigen
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRÄSENTATION
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Inhalt anzeigen
Renal protection with SGLT2 inhibitors: what every cardiologist should know
PRÄSENTATION
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Inhalt anzeigen
Alle Infektionen und Impfstoffe-Präsentationen anzeigen
Metabolic
NEUIGKEITEN

Metabolisch

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
PRÄSENTATION
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Inhalt anzeigen
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
PRÄSENTATION
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Inhalt anzeigen
Clinical recommendations for the management of type 2 diabetes
PRÄSENTATION
Clinical recommendations for the management of type 2 diabetes
Inhalt anzeigen
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRÄSENTATION
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Inhalt anzeigen
Alle Metabolisch-Präsentationen anzeigen
Oncology
NEUIGKEITEN

Onkologie

Optimizing HF discharge care and follow-up
PRÄSENTATION
Optimizing HF discharge care and follow-up
Inhalt anzeigen
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
PRÄSENTATION
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Inhalt anzeigen
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
PRÄSENTATION
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Inhalt anzeigen
Renal protection with SGLT2 inhibitors: what every cardiologist should know
PRÄSENTATION
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Inhalt anzeigen
Alle Onkologie-Präsentationen anzeigen
Renal
NEUIGKEITEN

Nieren

Chronic kidney disease management
PRÄSENTATION
Chronic kidney disease management
Inhalt anzeigen
Renal protection with SGLT2 inhibitors: what every cardiologist should know
PRÄSENTATION
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Inhalt anzeigen
Kidney outcomes associated with inhibition of SGLT2
PRÄSENTATION
Kidney outcomes associated with inhibition of SGLT2
Inhalt anzeigen
Medicines in chronic kidney disease
PRÄSENTATION
Medicines in chronic kidney disease
Inhalt anzeigen
Alle Nieren-Präsentationen anzeigen
Respiratory and Immunology
NEUIGKEITEN

Atmungs- und Immunologie

What did the study tell us about the safety of medicines in heart failure?
PRÄSENTATION
What did the study tell us about the safety of medicines in heart failure?
Inhalt anzeigen
Optimizing HF discharge care and follow-up
PRÄSENTATION
Optimizing HF discharge care and follow-up
Inhalt anzeigen
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRÄSENTATION
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Inhalt anzeigen
Medicines in chronic kidney disease
PRÄSENTATION
Medicines in chronic kidney disease
Inhalt anzeigen
Alle Atmungs- und Immunologie-Präsentationen anzeigen
Rare Disease
NEUIGKEITEN

Seltene Krankheit

What did the study tell us about the safety of medicines in heart failure?
PRÄSENTATION
What did the study tell us about the safety of medicines in heart failure?
Inhalt anzeigen
Hiding in plain sight – how to detect heart failure in primary care
PRÄSENTATION
Hiding in plain sight – how to detect heart failure in primary care
Inhalt anzeigen
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRÄSENTATION
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Inhalt anzeigen
Medicines in chronic kidney disease
PRÄSENTATION
Medicines in chronic kidney disease
Inhalt anzeigen
Alle Seltene Krankheit-Präsentationen anzeigen
Blickpunkt
NEUIGKEITEN

Aktuelle Inhalte

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
PRÄSENTATION
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
Inhalt anzeigen
Cardiologist Practical Guide to Prescribing
Infografik
Cardiologist Practical Guide to Prescribing
Inhalt anzeigen
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
VIDEO
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
Inhalt anzeigen
Cardiorenal benefits of SGLT2 inhibitors
PRÄSENTATION
Cardiorenal benefits of SGLT2 inhibitors
Inhalt anzeigen
Diagnosis and co-morbidities of chronic kidney disease
VIDEO
Diagnosis and co-morbidities of chronic kidney disease
Inhalt anzeigen